November 2008 Oncology News International

Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations

Nivolumab with ipilimumab elicited improvements to progression-free survival in patients with microsatellite instability–high colorectal cancer.

A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.

Rachel A. Greenup, MD, MPH

A Phase 1 Clinical Trial of NKTR-255 With CD19-22 CAR T-Cell Therapy for Refractory B-Cell Acute Lymphoblastic Leukemia

A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.

$A Phase 1 Clinical Trial of NKTR-255 With CD19-22 CAR T-Cell Therapy for Refractory B-Cell Acute Lymphoblastic Leukemia$

American Society for Transplantation and Cellular Therapy

Highlighting Advocacy Impacts on Funding for Kidney Cancer Research

Researchers at Stanford University have conducted a phase 1 clinical trial evaluating the combination of a bispecific CAR T-cell therapy targeting CD19 and CD22 with NKTR-255.

Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.

Elizabeth P. Henske, MD;Jason B. Muhitch, PhD

December 16th 2024

Additional Excision of Margin Tissue Did Not Alter Satisfaction in Breast Cancer

Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.

PM8002/BNT327 Combo Improves Efficacy and Safety in Metastatic TNBC

LumiSystem prompted the removal of a median of 10.5cc extra tumor margin tissue in patients with breast cancer and did not significantly affect satisfaction outcomes.

Nivolumab/Ipilimumab Approved for First-Line MSI-H/dMMR mCRC in Europe

Data from a phase 1b/2 study show a 78.6% ORR in patients with metastatic triple-negative breast cancer treated with PM8002/BNT327 plus nab-paclitaxel.

Related Content

Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations

Nivolumab with ipilimumab elicited improvements to progression-free survival in patients with microsatellite instability–high colorectal cancer.

Rachel A. Greenup, MD, MPH

A Phase 1 Clinical Trial of NKTR-255 With CD19-22 CAR T-Cell Therapy for Refractory B-Cell Acute Lymphoblastic Leukemia

A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.

$A Phase 1 Clinical Trial of NKTR-255 With CD19-22 CAR T-Cell Therapy for Refractory B-Cell Acute Lymphoblastic Leukemia$

American Society for Transplantation and Cellular Therapy

Highlighting Advocacy Impacts on Funding for Kidney Cancer Research

Researchers at Stanford University have conducted a phase 1 clinical trial evaluating the combination of a bispecific CAR T-cell therapy targeting CD19 and CD22 with NKTR-255.

Elizabeth P. Henske, MD;Jason B. Muhitch, PhD

December 16th 2024

Additional Excision of Margin Tissue Did Not Alter Satisfaction in Breast Cancer

Two oncologists discuss the impact of advocacy in kidney cancer research, highlighting collaboration between researchers, advocates, and physicians.

PM8002/BNT327 Combo Improves Efficacy and Safety in Metastatic TNBC

LumiSystem prompted the removal of a median of 10.5cc extra tumor margin tissue in patients with breast cancer and did not significantly affect satisfaction outcomes.